Coronary Disease Association With ADAMTS7 Is Due to Protease Activity.


Journal

Circulation research
ISSN: 1524-4571
Titre abrégé: Circ Res
Pays: United States
ID NLM: 0047103

Informations de publication

Date de publication:
06 08 2021
Historique:
pubmed: 29 6 2021
medline: 11 1 2022
entrez: 28 6 2021
Statut: ppublish

Résumé

[Figure: see text].

Identifiants

pubmed: 34176299
doi: 10.1161/CIRCRESAHA.121.319163
pmc: PMC8349873
mid: NIHMS1720258
doi:

Substances chimiques

ADAMTS7 Protein EC 3.4.24.-
ADAMTS7 protein, human EC 3.4.24.-

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

458-470

Subventions

Organisme : NHLBI NIH HHS
ID : K24 HL105780
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL092577
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL128914
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

Medicine (Baltimore). 2019 Oct;98(43):e17438
pubmed: 31651847
Nat Rev Genet. 2017 Jun;18(6):331-344
pubmed: 28286336
Nat Genet. 2011 Mar 06;43(4):339-44
pubmed: 21378988
Am J Hum Genet. 2013 Mar 7;92(3):366-74
pubmed: 23415669
J Med Chem. 2014 Dec 26;57(24):10476-85
pubmed: 25415648
J Biol Chem. 2004 Aug 20;279(34):35159-75
pubmed: 15192113
J Am Heart Assoc. 2017 Oct 31;6(11):
pubmed: 29089340
EMBO J. 2006 Nov 15;25(22):5270-83
pubmed: 17082774
J Biol Chem. 2001 May 25;276(21):17932-40
pubmed: 11279086
Oncogene. 2010 May 20;29(20):3025-32
pubmed: 20208563
Stroke. 2014 Jan;45(1):24-36
pubmed: 24262325
Circulation. 2015 Mar 31;131(13):1191-201
pubmed: 25712208
Physiol Genomics. 2016 Nov 1;48(11):810-815
pubmed: 27614204
Sci China Life Sci. 2015 Jul;58(7):674-81
pubmed: 25921940
J Biol Chem. 2006 Jun 9;281(23):15800-8
pubmed: 16611630
Matrix Biol. 2018 Oct;71-72:225-239
pubmed: 29885460
Protein Sci. 2014 Feb;23(2):123-44
pubmed: 24596965
Circulation. 2015 Mar 31;131(13):1202-1213
pubmed: 25712206
Cardiovasc Res. 2018 Jul 15;114(9):1241-1257
pubmed: 29617720
J Biol Chem. 2019 May 17;294(20):8037-8045
pubmed: 30926607
Lancet. 2011 Jan 29;377(9763):383-92
pubmed: 21239051
Methods Mol Biol. 2020;2043:63-73
pubmed: 31463903
Circ Res. 2014 May 23;114(11):1684-9
pubmed: 24677271
Genome Biol. 2015 May 30;16:113
pubmed: 26025392
Arterioscler Thromb Vasc Biol. 2001 Jan;21(1):47-54
pubmed: 11145932
Protein Sci. 2008 Jan;17(1):16-21
pubmed: 18042673
Sci Rep. 2017 Jun 16;7(1):3753
pubmed: 28623250
Methods Mol Biol. 2012;843:169-76
pubmed: 22222531
JCI Insight. 2018 Apr 5;3(7):
pubmed: 29618652
Cell Mol Life Sci. 2008 Mar;65(5):672-86
pubmed: 18193164
Nat Genet. 2011 Mar 06;43(4):333-8
pubmed: 21378990
Biochem Biophys Res Commun. 2016 Mar 11;471(3):380-5
pubmed: 26872430
Circulation. 2009 Nov 17;120(20):1996-2005
pubmed: 19884470
Br J Pharmacol. 2019 Jan;176(1):52-66
pubmed: 29488211
Circ Res. 2009 Mar 13;104(5):688-98
pubmed: 19168437
FASEB J. 2006 May;20(7):988-90
pubmed: 16585064

Auteurs

Taiji Mizoguchi (T)

Cardiovascular Disease Initiative (T.M., B.T.M., B.B., N.R.P., A.A., D.L., Q.M.Z., S.K., P.T.E.), Broad Institute of MIT and Harvard, Cambridge, MA.
Now with Verve Therapeutics, Cambridge, MA, USA (T.M., S.K.).

Bryan T MacDonald (BT)

Cardiovascular Disease Initiative (T.M., B.T.M., B.B., N.R.P., A.A., D.L., Q.M.Z., S.K., P.T.E.), Broad Institute of MIT and Harvard, Cambridge, MA.

Bidur Bhandary (B)

Cardiovascular Disease Initiative (T.M., B.T.M., B.B., N.R.P., A.A., D.L., Q.M.Z., S.K., P.T.E.), Broad Institute of MIT and Harvard, Cambridge, MA.

Nicholas R Popp (NR)

Cardiovascular Disease Initiative (T.M., B.T.M., B.B., N.R.P., A.A., D.L., Q.M.Z., S.K., P.T.E.), Broad Institute of MIT and Harvard, Cambridge, MA.

Dylan Laprise (D)

Center for the Development of Therapeutics (D.L., Y.X., V.K.K.), Broad Institute of MIT and Harvard, Cambridge, MA.

Alessandro Arduini (A)

Cardiovascular Disease Initiative (T.M., B.T.M., B.B., N.R.P., A.A., D.L., Q.M.Z., S.K., P.T.E.), Broad Institute of MIT and Harvard, Cambridge, MA.

Daniel Lai (D)

Cardiovascular Disease Initiative (T.M., B.T.M., B.B., N.R.P., A.A., D.L., Q.M.Z., S.K., P.T.E.), Broad Institute of MIT and Harvard, Cambridge, MA.

Qiuyu Martin Zhu (QM)

Cardiovascular Disease Initiative (T.M., B.T.M., B.B., N.R.P., A.A., D.L., Q.M.Z., S.K., P.T.E.), Broad Institute of MIT and Harvard, Cambridge, MA.
Center for Genomic Medicine (Q.M.Z., S.K.), Massachusetts General Hospital, Boston.

Yi Xing (Y)

Center for the Development of Therapeutics (D.L., Y.X., V.K.K.), Broad Institute of MIT and Harvard, Cambridge, MA.

Virendar K Kaushik (VK)

Center for the Development of Therapeutics (D.L., Y.X., V.K.K.), Broad Institute of MIT and Harvard, Cambridge, MA.

Sekar Kathiresan (S)

Cardiovascular Disease Initiative (T.M., B.T.M., B.B., N.R.P., A.A., D.L., Q.M.Z., S.K., P.T.E.), Broad Institute of MIT and Harvard, Cambridge, MA.
Now with Verve Therapeutics, Cambridge, MA, USA (T.M., S.K.).
Center for Genomic Medicine (Q.M.Z., S.K.), Massachusetts General Hospital, Boston.

Patrick T Ellinor (PT)

Cardiovascular Disease Initiative (T.M., B.T.M., B.B., N.R.P., A.A., D.L., Q.M.Z., S.K., P.T.E.), Broad Institute of MIT and Harvard, Cambridge, MA.
Cardiovascular Research Center (P.T.E.), Massachusetts General Hospital, Boston.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH